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Abstract
BACKGROUND: The aim of this paper is a description of our
experience with scintigraphic detection of brain death.
MATERIAL AND METHODS: Thirty-four patients were studied
from February 2003 to June 2006. We performed brain scinti-
graphic examination utilising 99mTc-HMPAO and a two-headed
SPECT camera E.CAM. We used LEHR collimators. 15% ener-
gy window was centred around 140 keV. 650750 MBq of ra-
diopharmaceutical was injected as a bolus. Then dynamic scin-
tigraphy of the head and neck was done in an anterior projec-
tion  2 s per frame for 60 s. Then static scintigraphy of the
head in four projections followed (anterior, both lateral and pos-
terior views), for 4 minutes per view.
RESULTS: A typical picture of brain death on planar dynamic
and static scintigrams showed an absence of perfusion and
radiopharmaceutical accumulation in both cereberal and cere-
bral hemispheres and brain stem. Radioactivity in the area of
the scalp and face could be present. Borderline findings, which
demanded careful interpretation, were the cases with preserva-
tion of minimal cerebral perfusion and simultaneous absence
of radiopharmaceutical accumulation in its parenchyma and cut-
off of tracer accumulation in cerebral parenchyma only supra-
or infratentorial.
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CONCLUSIONS: Cerebral perfusion scintigraphy is the most
contributing factor for the diagnosis of brain death in patients
after cranial trauma with subsequent neurosurgical operation,
when angiography is often unsuitable. In these situations per-
fusion scintigraphy is able to show the absence of radiophar-
maceutical accumulation in cerebral tissue. Scintigraphic de-
tection of brain death gained an important role in new Czech
legislation, and the demands of transplant centres for these
examinations will certainly grow with the accrual of organ col-
lections.
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Introduction
Before organ transplantation from dead donors it is neces-
sary to determine irreversible brain changes and brain death. Brain
scintigraphy plays an important role in this.
Material and methods
Thirty-four patients (age range 365 yrs; average age 37.6
yrs; 22 men and 12 women) were studied from February 2003 to
June 2006 (patients data are given in Tables 1 and 2).
The method of scintigraphic procedure is based on the guide-
lines of the Board of the Czech Society of Nuclear Medicine [1, 2].
We performed this study utilising the  99mTc- hexamethyl-pro-
pylene-amine-oxime (HMPAO) (BRAIN-SPECT, Fodor JózsØf
National Centre of Public Health, FrØdØric Joliot-Curie National
Research Institute for Radiobiology and Radiohygiene, Budap-
est, Hungary), for its very easy preparation and quick and easy
determination of radiochemical purity. We could perform the ce-
rebral perfusion scintigraphy on any day of the week. The radiop-
harmaceutical was prepared exactly according to the producers
instructions and in the time specified by the producer. We carried
out quality control of labelling and stability of the compound and
radiochemistry purity before the injection of radiopharmaceutical.
Assessment of radiochemical purity of 99mTc- hexamethyl-propy-
lene-amine-oxime: into a test tube with 3.0 ml chloroform and
2.9 ml 0.9% solution of sodium chlorate we added 0.1 ml of pre-
pared 99mTc-HMPAO which we shook intensively for 1 minute. We
left the test tube at rest for 1-2 minutes to facilitate phase separa-
tion. Then we completely transferred one of the phases to the
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second tube. We measured the activity of both test tubes (both
phases). A lipophilic complex of 99mTc-HM-PAO was located in the
chloroform phase and contaminants in the solution of sodium chlo-
rate. The result was expressed as a percentage of radiochemical
purity.  The radiopharmaceutical could be used for 2 hours after
preparation, and minimal acceptable radiochemistry purity is 80%.
We performed brain scintigraphy utilising the two-headed SPECT
camera E.CAM (Siemens, Erlangen, Germany). We used LEHR col-
limators. A 15% energy window was centred around 140 keV.
650750 MBq of radiopharmaceutical was injected as a bolus.
Then dynamic scintigraphy of the head and neck was performed
in anterior projection  2 s per frame for 60 s (matrix 64 × 64,
zoom 1.0). Then statical scintigraphy of the head in four projec-
tions followed (in anterior, both lateral and posterior views) for
4 minutes per view (matrix 128 × 128, zoom 1.0).
We evaluated the scintigraphic images as follows: typical picture
of brain death on dynamic scintigrams as the absence of perfusion
and on planar static scintigrams the absence of radiopharmaceuti-
cal accumulation in both cerebral and cereberal hemispheres and
brain stem, absence of internal carotid circulation and the circle of
Willis circulation. Radioactivity in the area of scalp and face can be
present. Borderline findings which demanded careful interpretation
were included cases with preservation of minimal cerebral perfusion
and simultaneous absence of radiopharmaceutical accumulation in
its parenchyma. The mere presence of sagittal venous sinus in the
absence of demonstrable cerebral arterial flow activity is not clinically
significant and does not contradict the diagnosis of brain death [3].
Results
We performed this examination on 34 patients as possible
organ donors; in all of them we established brain death.
In Figures 1A, 1B and 2 we show the dynamic and static scinti-
grams of a patient (woman aged 47 yrs) with subarachnoid haemor-
Table 1. Classification of patients: sex, age, conditions, surgery
Pts no. Sex Age Conditions Surgery
1 M 9 Spontaneous cerebral  haemorrhage YES
2 M 52 Cranial injury YES
3 M 10 Multiple injury, cranial injury NO
4 M 30 Cranial injury, subdural haematoma NO
5 M 38 Subdural haematoma, brain oedema YES
6 M 37 Cranial injury, brain contusion,
brain oedema NO
7 M 52 Subdural haematoma, brain oedema YES
8 F 61 Spontaneous cerebral  haemorrhage YES
9 M 50 Cerebral  haemorrhage YES
10 M 20 Craniocerebral injury YES
11 F 26 Cerebral  haemorrhage, AV malformation YES
12 M 10 Multiple injury, cranial injury YES
13 M 36 Cranial injury in ebrietas YES
14 F 51 Spontaneous cerebral haemorrhage YES
15 M 18 Spontaneous cerebral haemorrhage YES
16 F 52 Spontaneous cerebral haemorrhage YES
17 M 40 Spontaneous cerebral haemorrhage YES
18 F 11 Malignant brain edema in obstructive
hydrocephalus YES
19 M 47 Cranial injury in ebrietas YES
20 F 61 Malignant brain edema after
cerebral ischemia YES
21 F 36 Status after astrocytoma extirpation,
brain edema NO
22 M 24 Cranial injury in epileptic paroxysm YES
23 M 14 Cranial injury, malignant brain edema,
hemocephalus NO
24 F 39 Subarachnoidal haemorrhage,
malignant brain edema YES
25 F 47 Subarachnoidal haemorrhage,
malignant brain edema YES
26 M 55 Cranial injury, subdural haemorrhage YES
27 F 43 Cranial injury, subdural haemorrhage,
brain edema YES
28 M 47 Brain contusion, malignant brain edema YES
29 M 3 Malignant brain edema after operation NO
30 F 39 Cranial injury YES
31 M 65 Intracranial haemorrhage YES
32 M 46 Brain contusion, subdural and epidural
haemorrhage, brain oedema YES
33 F 59 Brain aneurysm rupture YES
34 M 52 Cranial injury, subdural haemorrhage YES
M  man; F  female
Table 2. Clasification of parents: type of organ withdrawal
Pts no. Organ withdrawal
1 Kidneys and heart
2 Kidneys
3 Kidneys, heart, lungs, liver
4 Heart, kidneys, pancreas
5 Kidneys, heart, liver
6 Kidneys and heart
7 Kidneys
8 Kidneys
9 Kidneys
10 Kidneys and heart
11 Kidneys, heart, lungs, liver
12 Kidneys and heart
13 Kidneys, heart, liver
14 Kidneys
15 Kidneys, heart, pancreas, liver
16 Kidneys
17 Kidneys and heart
18 Heart, lungs, liver, pancreas, kidneys
19 Kidneys
20 Kidneys
21 Multiple organ withdrawal
22 Multiple organ withdrawal
23 Multiple organ withdrawal
24 Multiple organ withdrawal
25 Multiple organ withdrawal
26 Multiple organ withdrawal
27 Multiple organ withdrawal
28 Withdrawal contraindicated  positive serology for syphilis
29 Withdrawal was not performed
30 Multiple organ withdrawal
31 Kidneys
32 Multiple organ withdrawal
33 Multiple organ withdrawal
34 Multiple organ withdrawal
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Figure 1.A.B. Dynamic brain scintigraphy in a 47 yr old woman with subarachnoidal haemorrhage, malignant brain oedema and after bilateral neurosurgery
(anterior projection, acquisition 60 seconds, 30 frames, 2 seconds per frame). No brain perfusion.
A
B
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rhage and malignant brain oedema after bilateral neurosurgery (bi-
lateral external decompression surgery). No radiopharmaceutical
accumulation in either cerebral and cereberal hemisphere or brain
stem is visible (sign of so-called hollow skull). On the basis of scin-
tigraphic results, brain death was established. For comparison we
have also shown dynamic and static scintigrams taken before brain
SPECT in a patient (man aged 47 yrs) examined after a stroke (Fig-
ure 3A, 3B and Figure 4A, 4B). Normal cerebral perfusion is evident.
Discussion
In the majority of European countries recommendations have
been published for the diagnosis of brain death as a necessary
prerequisite for organ donation. The concept of brain death as
defining the death of the individual is accepted in all European
countries; however, the guidelines for determining the total and
irreversible loss of all brain function differ somewhat in the various
countries. While the clinical examinations and documentation of
the clinical signs of brain death are very uniform, there are signif-
icant differences in the guidelines for using technical confirmatory
tests to corroborate the clinical signs [4]. For example, in Croatia,
the Czech Republic, Slovenia and Switzerland brain scintigraphy
is mandatory or accepted as one of the ancillary methods. In Aus-
tria neurological examination, MRI or angiography is crucial, in
Sweden neurological examination and angiography, in Finland CT,
MRI angiography and rtg angiography, in Turkey EEG and clinical
examination, sometimes angiography; scintigraphy not manda-
tory and in Slovakia neurology and angiography.
A common indication of brain death scintigraphy is to assess
brain blood flow in patients suspected of brain death.
Figure 2. Static brain scintigraphy in the same patient as in Figures 1a and
1b (anterior, posterior and both lateral projections, 4 minutes per frame;
anterior and posterior projections are done simultaneously, both lateral pro-
jections are also performed simultaneously). No brain perfusion.
Our University Hospital has developed clinical guidelines and
procedures for clinical diagnosis, including performing scintigra-
phy for assessing possible brain death. These guidelines include
repeated neurological examinations with a special focus on the
absence of brain stem reflexes (the minimum time between first
and second neurological examinations is 4 hours) [5]. These guide-
lines also include ancillary tests such as perfusion scintigraphy
and angiography.
According the Czech government enactment number 436/
/2002 and the so-called Czech Transplantation Act number 285/
/2002 it is necessary to perform cerebral angiography or cerebral
perfusion scintigraphy (in the department of nuclear medicine) for
the verification of the irreversibility of clinical signs of brain death.
Angiographic detection of brain death is based on the suppo-
sition that upon brain death accrual of brain oedema with subse-
quent increase of intracranial pressure, which eventually exceeds
systolic pressure (critical closing pressure), gradually leads to fail-
ure of cerebral circulation. This is why it is requested that cerebral
angiography (and also brain scintigraphy) be performed (and also
brain scintigraphy) at a mean pressure of 6080 mm Hg to ex-
clude the situation in which cessation of cerebral circulation will
be induced by the low systolic (perfusion) pressure.
Cerebral angiography is performed as digital subtraction an-
giography (DSA) by a certified radiologist utilising a minimum vol-
ume of 30 ml Omnipaque.
Validation of brain death is confirmation of brain circulation
cessation. In patients with some types of cranial injuries or after
craniectomy, cerebral blood flow can be partially preserved. In
such cases, penetration of Omnipaque to some cerebral arteries
does not exclude brain death, and in these patients brain death
cannot be confirmed.
In these situations brain scintigraphy plays the main role.
The method of scintigraphic procedure is based on the guide-
lines of the board of the Czech Society of Nuclear Medicine which
was inspired by the Society of Nuclear Medicine (SNM) Proce-
dure Guidelines for Brain Death Scintigraphy [6].
To meet the criteria for whole-brain death, perfusion must be
absent in the whole brain, both cerebrum and cerebellum [7]. We
agree with Spieth et al. [7, 8] that without the use of agents trapped
in brain tissue for a relatively long time, accurate evaluation of
brain perfusion is not possible.  At this time HMPAO and Neurolite
are the only available technetium-labelled agents able to meet the
strict criteria for the clinical confirmation of whole-brain death [8,
9]. After the application of the radiopharmaceutical its accumula-
tion is proportional to the regional perfusion of the brain, and con-
firms cell viability. The absence of radiopharmaceutical accumu-
lation in brain tissue detected by scintigraphy confirms brain death.
In static scintigraphy it is important to perform anterior, both later-
al and posterior projections [7]. The examination in our depart-
ment is done by physicians with nuclear medicine attestation.
We perform qualitative visual assessment of the presence or
absence of delayed 99mTc- HMPAO deposition in the brain.
After dynamic and static scintigraphy it is possible to supple-
ment by SPECT examination [10, 11]. It is also possible to per-
form some semi-quantitative evaluation (for example to calculate
blood flow index, i.e. the ratio of the area under the brain time-
activity curve vs that under the curve for the carotid arteries; and
delayed uptake index, i.e. the ratio of 99mTc-HMPAO deposition in
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Figure 3.A.B. Dynamic brain scintigraphy in a 47 yr old man after stroke (anterior projection, acquisition 60 seconds, 30 frames, 2 seconds per frame).
Normal brain perfusion is visible.
B
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the brain vs. that in the facial regions of interest) [12]. But we
believe that tomographic scintigraphy and some calculations are
not necessary. In our 34 patients brain death was determined with-
out problem by means of static and dynamic scintigraphy, with-
out SPECT and without any calculation.
Conclusions
Cerebral perfusion scintigraphy is the greatest contribution in
the diagnosis of brain death in patients after cranial trauma with
subsequent neurosurgery intervention, when (according to the
experience of our radiologists) angiography is often unsuitable
(for long-term filling of  cerebral arteries). In these situations per-
fusion scintigraphy is able to show the absence of radiopharma-
ceutical accumulation in cerebral tissue.
In a limited number of uncertain findings in perfusion scinti-
grams, nuclear medicine physicians must not confirm the absence
of tracer accumulation in the brain by its own signature (in Czech
government enactment number 436/2002).
Brain scintigraphy is a simple and reliable method for this
purpose.
Scintigraphic detection of brain death has gained an impor-
tant role in the new Czech legislation, and the demands of trans-
plant centres for these examinations will certainly  grow markedly
with the accrual of organ collections.
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Figure 4.A.B. Static brain scintigraphy in the same patient as in Figure 3AB (Figure 4A  anterior and posterior projections; Figure 4B  both lateral
projections; 4 minutes per frame; anterior and posterior projections are carried out simultaneously, both lateral projections are also performed simulta-
neously. Normal brain perfusion is visible.
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